Stock 300122 CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Chongqing Zhifei Biological Products Co., Ltd.

Equities

300122

CNE100000V20

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
34.08 CNY -3.70% Intraday chart for Chongqing Zhifei Biological Products Co., Ltd. -19.07% -44.23%
Apr. 23 Chongqing Zhifei Biological Products' 2023 Profit Rises 7%; Shares Plunge 12% MT
Apr. 22 Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Chongqing Zhifei Biological Products' 2023 Profit Rises 7%; Shares Plunge 12%
MT
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback Plan announced on February 22, 2024.
CI
Chongqing Zhifei Biological Products Co., Ltd.'s Equity Buyback announced on February 22, 2024, has closed with 6,210,253 shares, for CNY 300.01 million.
CI
Chongqing Zhifei Biological Products Co., Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.
CI
Chongqing Zhifei Biological Products Co., Ltd. authorizes a Buyback Plan.
CI
Zhifei Biological Falls After Merck Secures Nod to Market HPV Vaccine in China
MT
Zhifei Biological Products to Acquire Local Biopharma Firm, Expanding Into Metabolic Disease Treatments
MT
Chongqing Zhifei Biological Products Co., Ltd. signed a letter of intent to acquire Shanghai Polaris Biology Co., Ltd.
CI
Chongqing Zhifei Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Middle East Conflict Weighs on Exchange-Traded Funds, Equity Futures Pre-Bell Monday
MT
GSK Signs Distribution Deal With China's Zhifei for Shingles Vaccine
MT
Chongqing Zhifei Biological Enters Exclusive Distribution Deal With GSK
MT
Trending : GSK Signs $3 Billion Shingles Vaccine Deal in China
DJ
GSK Strikes $3.06 Billion Shingles Vaccine Deal With China's Zhifei -- Update
DJ
European Midday Briefing : Oil Surges, Stocks Fall on Middle East Conflict
DJ
GSK inks agreement with Zhifei to promote shingles vaccine
AN
GSK Secures GBP2.5 Billion Partnership for Shingles Vaccine in China
MT
GSK signs shingles vaccine deal with China's Zhifei for about $3 bln
RE
Metro Bank secures deal to shore up finances
AN
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300122 Stock
  4. News Chongqing Zhifei Biological Products Co., Ltd.